Actively Recruiting
Validation of the Performance of the French Version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a Screening Test for Cerebellar Cognitive-affective Syndrome: a National Multicenter Study
Led by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · Updated on 2025-05-16
217
Participants Needed
1
Research Sites
172 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective of the study is to assess the performance of the French version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a screening test for cerebellar cognitive-affective syndrome. The primary endpoint will be the sensitivity of version 1A of the French scale. The result will be considered positive if the patient fails at least one of the scale's subtests. The diagnosis of a cerebellar cognitive-affective syndrome will be made on the basis of a pathological score in the executive, language, visuospatial or psychoaffective domains of the neuropsychological evaluation (gold standard).
CONDITIONS
Official Title
Validation of the Performance of the French Version of the Cerebellar Cognitive-Affective Syndrome Scale (CCASS) as a Screening Test for Cerebellar Cognitive-affective Syndrome: a National Multicenter Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- French speaking
- Acquired lesion or predominantly degenerative cerebellar pathology of any etiology
- Affiliated or beneficiary of a social security scheme
- Written informed consent
You will not qualify if you...
- History or progressive pathology of the central nervous system other than cerebellar disease
- Chronic ethylic patient with active consumption, or alcohol withdrawal of less than three months
- Use of other toxic substances
- Blind or severely visually impaired patient
- Deaf or severely hearing-impaired patient unable to understand instructions
- Mute patient
- Patient deprived of liberty or under legal protection
- Patients with incomplete French scale and/or neuropsychological assessment will be replaced.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
GHRMSA
Mulhouse, Haut-Rhin, France, 68100
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here